Cargando…
Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
BACKGROUND: We aimed to evaluate the age‐dependent effect of ticagrelor monotherapy after 3‐month dual‐antiplatelet therapy (DAPT) versus ticagrelor‐based 12‐month DAPT on major bleeding and cardiovascular events in patients with acute coronary syndrome. METHODS AND RESULTS: From the TICO trial (Tic...
Autores principales: | Kim, Byung Gyu, Hong, Sung‐Jin, Kim, Byeong‐Keuk, Lee, Seung‐Jun, Ahn, Chul‐Min, Shin, Dong‐Ho, Kim, Jung‐Sun, Ko, Young‐Guk, Choi, Donghoon, Hong, Myeong‐Ki, Jang, Yangsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075234/ https://www.ncbi.nlm.nih.gov/pubmed/34873925 http://dx.doi.org/10.1161/JAHA.121.022700 |
Ejemplares similares
-
Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
por: Kim, Byung Gyu, et al.
Publicado: (2023) -
Factors Related to Major Bleeding After Ticagrelor Therapy: Results from the TICO Trial
por: Cho, Jae Young, et al.
Publicado: (2021) -
Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
por: Yun, Kyeong Ho, et al.
Publicado: (2021) -
Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial
por: Cho, Jae Young, et al.
Publicado: (2023) -
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
por: Lee, Yong-Joon, et al.
Publicado: (2021)